COVID-19 Vaccine With Patch Delivery Technology Enters Preclinical Testing at UC Davis (IMAGE)

University of California - Davis

COVID-19 Vaccine With Patch Delivery Technology Enters Preclinical Testing at UC Davis

Caption

Daniel R. Henderson, inventor of the VaxiPatch and CEO of Verndari, Inc. shows a prototype package of the VaxiPatch and magnified image of the microneedle array dermal patch. The company is beginning preclinical testing at UC Davis of the device to deliver a vaccine for COVID-19.

Credit

Rudy Meyers Photography

Usage Restrictions

May be used with acknowledgement.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.